The Hematology T32 Training Grant at the University of North Carolina at Chapel Hill (UNC-CH) is committed to the training of both physician-scientists and PhD scientists for careers in hematology research as well as in all other aspects of academic hematology. This NHLBI-funded training program that has been in existence for well over 30 years has trained and produced numerous outstanding, nationally prominent scientists, many of whom have now gone on to become leaders in academic hematology. Under a completely reorganized leadership team, this program will continue to train both adult and pediatric hematology-oncology fellows and PhD post-doctoral awardees in a wide variety of research areas that reflect traditional Institutional strengths. These areas encompass both benign hematology (e.g., coagulation, vascular biology, sickle cell anemia, hematopoiesis, etc.) and malignant hematology (e.g., immunology, virology, gene transfer, molecular mechanisms of neoplasia, etc.). Both basic bench and clinical research tracks are available, with carefully selected didactics from the K30 curriculum and other coursework, both mandatory and optional. In this renewal application, scientific and educational interactions between MD and PhD trainees have been enhanced through conferences, journal clubs, and symposia. Following 2 years of training on the T32 grant, trainees will be encouraged to apply for institutional and/or individual 'K'series awards as well as to seek other sources of independent research funding. In this respect, UNC-CH has had a long-standing and passionate commitment to the career development of many of its young people. Using both institutional funds (the UNC Minority Scholar Program, the UNC Program in Translational Science) and NIH K12 Awards (the BIRCWH Award, the NCRR K12 Award, the Roadmap K12 Award), we have been able to fund both former and current hematology T32 trainees as they make the transition from mentored to independent investigator status.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007149-34
Application #
7798501
Study Section
Special Emphasis Panel (ZHL1-CSR-J (O1))
Program Officer
Mondoro, Traci
Project Start
1975-07-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
34
Fiscal Year
2010
Total Cost
$367,607
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hisada, Yohei; Thålin, Charlotte; Lundström, Staffan et al. (2018) Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients. Thromb Res 165:1-5
Beckman, Joan D; Kasthuri, Raj S; Wolberg, Alisa S et al. (2018) Challenges in diagnosis and management of acquired factor XIII (FXIII) inhibitors. Haemophilia 24:e417-e420
Klein, Mia; Chang, Alicia K; Vasudevan, Sanjeev A et al. (2018) Clinically significant ascites as an indication for resection of rapidly involuting congenital hepatic hemangiomas. Pediatr Blood Cancer 65:e27222
Beckman, Joan D; Rollins-Raval, Marian A; Raval, Jay S et al. (2018) Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura. Am J Ther 25:e270-e272
Beckman, J D; Holle, L A; Wolberg, A S (2018) Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin ?-chain crosslinking. J Thromb Haemost 16:131-141
Hisada, Yohei; Mackman, Nigel (2018) Mouse models of cancer-associated thrombosis. Thromb Res 164 Suppl 1:S48-S53
Pahl, Kristy S; Kim, Kyung; Sams, Casey et al. (2018) Inconsistency in classifying vascular anomalies: What's in a name? Pediatr Blood Cancer 65:
Houghton, Damon E; Moll, Stephan (2017) Antiphospholipid antibodies. Vasc Med 22:545-550
Martin, Karlyn A; Lee, Craig R; Farrell, Timothy M et al. (2017) Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance. Am J Med 130:517-524
Houghton, Damon E; Sud, Shivani; Moll, Stephan et al. (2017) Perils in the thrombophilia workup: Frequency and circumstances of erroneously ordered factor V activity tests for thrombophilia. Vasc Med 22:527-528

Showing the most recent 10 out of 72 publications